These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18651811)

  • 21. Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
    Boianelli A; Sharma-Chawla N; Bruder D; Hernandez-Vargas EA
    Front Cell Infect Microbiol; 2016; 6():60. PubMed ID: 27379214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuraminidase inhibitors and high risk of influenza complications: considered and widely-supported recommendations].
    van Dissel JT; Coutinho RA; van der Sande MA
    Ned Tijdschr Geneeskd; 2009; 153():B486. PubMed ID: 20051160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antivirals--current trends in fighting influenza.
    Król E; Rychłowska M; Szewczyk B
    Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
    Mawatari M; Saito R; Hibino A; Kondo H; Yagami R; Odagiri T; Tanabe I; Shobugawa Y;
    PLoS One; 2019; 14(11):e0224683. PubMed ID: 31697721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features of pneumonia associated with influenza virus infection].
    Fujita J
    Nihon Rinsho; 2003 Nov; 61(11):1936-44. PubMed ID: 14619435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives.
    Bassetti M; Castaldo N; Carnelutti A
    Expert Opin Pharmacother; 2019 Oct; 20(14):1711-1718. PubMed ID: 31169040
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
    Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
    BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?
    Parra-Rojas C; Nguyen VK; Hernandez-Mejia G; Hernandez-Vargas EA
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30149615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.
    Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y
    Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postviral Complications: Bacterial Pneumonia.
    Prasso JE; Deng JC
    Clin Chest Med; 2017 Mar; 38(1):127-138. PubMed ID: 28159155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: Neuraminidase inhibitors reduce symptomatic influenza; oseltamivir does not reduce hospitalizations.
    Millard PS
    Ann Intern Med; 2014 Oct; 161(8):JC2. PubMed ID: 25329219
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients.
    Lee N; Leo YS; Cao B; Chan PK; Kyaw WM; Uyeki TM; Tam WW; Cheung CS; Yung IM; Li H; Gu L; Liu Y; Liu Z; Qu J; Hui DS
    Eur Respir J; 2015 Jun; 45(6):1642-52. PubMed ID: 25573405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
    Hirotsu N; Saisho Y; Hasegawa T
    Influenza Other Respir Viruses; 2019 Mar; 13(2):123-132. PubMed ID: 29989680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmented lung inflammation protects against influenza A pneumonia.
    Tuvim MJ; Evans SE; Clement CG; Dickey BF; Gilbert BE
    PLoS One; 2009; 4(1):e4176. PubMed ID: 19137067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
    Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
    [No Abstract]   [Full Text] [Related]  

  • 36. New approaches to influenza chemotherapy. Neuraminidase inhibitors.
    Calfee DP; Hayden FG
    Drugs; 1998 Oct; 56(4):537-53. PubMed ID: 9806102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy.
    Noyola DE
    Paediatr Drugs; 2003; 5(2):125-31. PubMed ID: 12529164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should neuraminidase inhibitors be prescribed for patients with influenza?
    Patel DM; Pitts SR; Hargraves J
    Ann Emerg Med; 2014 Jan; 63(1):54-5. PubMed ID: 23932720
    [No Abstract]   [Full Text] [Related]  

  • 40. Global transmission of oseltamivir-resistant influenza.
    Moscona A
    N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.